SS
SIEGEL SUSAN E
Director
BoardF
Insider track record
Board DirectorAcross 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by SIEGEL SUSAN E, Director. Director active across 3 companies, notably Illumina, INC.. Aggregated, 18 filings have been published. Activity tracked since 19 May 2021. The latest transaction was disclosed on 20 May 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
1,745 shares0Common StockSEC:0001193125-26-237340:0
3,780 shares0Common StockSEC:0001127602-25-015502:0
1,148 shares0Common StockSEC:0001415889-25-014209:0
24,579 sharesCommon StockSEC:0000950170-25-050473:0
6,754 shares0Common StockSEC:0001610717-24-000366:0
19,169 shares0Common StockSEC:0001610717-24-000267:0
1,029 shares0Common StockSEC:0001415889-24-014028:0
2,622 shares0Common StockSEC:0001127602-24-015922:0
1,532 shares0Common StockSEC:0001127602-23-017241:0
6,754 shares0Common StockSEC:0001610717-23-000080:0
1,114 shares0Common StockSEC:0001209191-23-031147:0
4,155 shares0Common StockSEC:0001567619-22-011886:0
352 shares@ US$242.400.0004% mcap24.2% of flowCommon StockSEC:0001127602-22-015924:0
524 shares0Common StockSEC:0001209191-22-030710:0
385 shares@ US$397.090.0006% mcap37.9% of flowCommon StockSEC:0001127602-21-018204:0
385 shares@ US$397.0937.9% of flowCommon StockSEC:0001127602-21-018204
1,271 shares0Common StockSEC:0001209191-21-035060
1,271 shares0Common StockSEC:0001209191-21-035060:0
About SIEGEL SUSAN E
Susan E. Siegel is a Board Member at ALIGN TECHNOLOGY INC, ILLUMINA, INC., and NEVRO CORP. She provides her expertise in governance and strategy, contributing to guiding decisions and ensuring compliance. Her experience in the medical technology sector is a valuable asset to the board.